New results from the #PROOF-HD trial show #pridopidine may benefit individuals with #Huntington disease who are not taking antidopaminergic meds (ADMs), supporting its potential as a targeted therapy. ow.ly/gVEx50VxBh9 #Neurology #AANAM Prilenia American Academy of Neurology

For people with #Huntingtonsdisease or #ALS the need for advance care planning becomes an all too real necessity sooner than anyone would like. As we recognize National Healthcare Decisions Day today, it’s a great time for each of us to talk with our loved ones about our

It's springtime – time for yet more growth as we add two wonderful new faces to the Prilenia line-up! Welcome to the team Sara Forman and Angela Gonzalez de Castro!

"Your whole life is changing. Your personality, your wants, your desires, your abilities. Everything is changing." A patient describes life with #Huntingtonsdisease from the “Lived Experience of Patients with Huntington’s Disease and their Caregivers Participating in the

"Don't give in to guilt and shame - hidden no more" were the words uttered by #PopeFrancis at a special papal audience with the #Huntingtonsdisease community held in the #Vatican in September of 2017 - becoming the first Pope to publicly say the name "Huntington's disease",

In one of the biggest all-private deals of the year, totaling up to €500 million Prilenia and Ferrer announced that they’ve joined forces to advance #pridopidine in Europe and other select international markets through a commercialization and co-development agreement.

Turin was Italy's first capital apparently! And this week it became the #ALS capital of Europe as the ENCALS (European network to cure ALS) meeting brought together those striving to improve treatment of ALS - including us and our partner Ferrer - and where we presented

Neurodegenerative diseases don’t wait, neither do we. Together, Prilenia and our partner Ferrer, are on a mission to drive innovation in neuroprotective care for people living with Huntington’s disease, amyotrophic lateral sclerosis (ALS) and other rare neurodegenerative

Thanks to Eric Dane for sharing his ALS journey with Good Morning America and making sure others don’t feel alone in their ALS diagnosis. This is a devastating disease and he is bravely helping the world understand the challenges of living with ALS. We urgently need new

We’re heading to the EAN Congress with real momentum. Right now, the European Medicines Agency is reviewing the Marketing Authorization Application for pridopidine, with an outcome expected later this year. This is an important step in our journey to bring a new kind of therapy

A remarkable leader, an amazing journey, important destinations...Well worth deliberately getting stuck in traffic to have a listen to! linkedin.com/posts/kieranca…

Today is World Amyotrophic Lateral Sclerosis (ALS) Day, also known as Global MND Awareness Day. A fitting day to start things off at #EAN2025! Look out for our data presentations and don’t miss Dr Ralf Reilmann’s Forum Talk on Managing Patient Care Holistically in Huntington’s

We’re not just treating symptoms, our work aims to change the dynamic of Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS) and other rare neurodegenerative diseases. Helping to protect neurons from cellular stress and its effects before irreversible damage occurs is

Thank you to everyone who joined us at the EAN Congress – your insights and support help drive our mission forward. Neurodegenerative diseases don’t give second chances. We understand that everything changes for patients and their loved ones following a diagnosis of

Briden Roth, 13 years old, is the son of a member of the Prilenia team. He wanted to raise awareness of #Huntingtonsdisease and created this short film of the team’s participation in a recent HD event. Today, as the HDSA annual convention is taking place, it seems a fitting

Most cells in the body are able to proliferate, which enables old and damaged cells to be replaced. But neurons (nerve cells) - the primary cells of the brain - do not have this ability. So, while there is some evidence of neurogenesis in some parts of the brain, the vast

A meeting of minds and spirit! Amazing atmosphere of shared mission and purpose as the Prilenia and Ferrer teams met in Barcelona for their first face-to-face working session as partners. Brighter together and working together for a brighter future for people with

Disappointed but committed, alongside our partner Ferrer, to providing new much-needed options for patients. We are exploring all options for next steps and our plans for registrational studies in #Huntingtonsdisease and #ALS continue. PR on the CHMP recommendation to refuse the